Boston Heart Diagnostics Corp.
https://bostonheartdiagnostics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Boston Heart Diagnostics Corp.
Deals In Depth: December 2014
Pfizer received worldwide rights to Opko Health's Phase III human growth hormone Lagova; Merck and Otsuka made billion-dollar M&As in infectious and neurological diseases, respectively. Biopharma and device financing were down compared with November.
Medical Device Deals Update, January 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced December 2014-January 2015.
Deals Shaping The Medical Industry, January 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014.
Company Information
- Industry
- Services
-
Laboratory Testing Services
- Esoteric Laboratories
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Boston Heart Lab
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice